{
  "abstract": "The idea that a prolonged interval between diagnosing and treating uveal melanoma can affect prognosis has been at the centre of an active debate.1–5 This issue focuses on a key question for aggressive cancers that spread early: Does treating the primary tumour per se improve survival, or is it merely palliative once micrometastases have formed?6 7",
  "authors": [
    {
      "affiliations": [
        "Ocular Oncology and Pathology Services, St. Erik Eye Hospital, Stockholm, Sweden",
        "Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"
      ],
      "name": "Gustav Stålhammar"
    }
  ],
  "title": "Twelve reasons delays in uveal melanoma treatment might affect prognosis",
  "uid": "f2b24564-31b6-5f98-8549-080d3fffcc77"
}